Denodo Once Again Named a Customers’ Choice in the 2022 Gartner Peer Insights™ “Voice of the Customer”: Data Integration Tools
More than four out of five reviewers show willingness to recommend Denodo Platform to others…
More than four out of five reviewers show willingness to recommend Denodo Platform to others…
WASHINGTON–(BUSINESS WIRE)–The online wealth management and tracking platform has launched Cova to allow users to…
Distinction Showcases Outstanding Channel Leadership and Commitment to Innovative Partner Program AUSTIN, Texas–(BUSINESS WIRE)–M-Files Corporation,…
Online commerce powerhouses innovate, iterate and turn disruption into opportunities as retail continues its rapid…
Merger includes C$20 million investment to accelerate access to genomics-based testing for cancer treatment by…
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
The latest release of Ballerina open-source language extends unique ability to simultaneously code using text…
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15,…
BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
• FDA Agreed to PolyPid Request for the Addition of an Unblinded Interim Analysis in…
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
– In vitro studies indicate IGM-6268 exhibits potent neutralization activity against the Omicron variant and all other…
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited…
11th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country’s Largest Beer…
NEW YORK and VIENNA, Austria, Feb. 09, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
— Phase 1/2 ABILITY study of MDNA11 on track with first set of efficacy results…